{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Tiziana Life Sciences Ltd"},"Symbol":{"label":"Symbol","value":"TLSA"},"Address":{"label":"Address","value":"2 CHURCH STREET,CLARENDON HOUSE, HAMILTON, HM 11, Bermuda"},"Phone":{"label":"Phone","value":"+44 207495237"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"Europe"},"CompanyDescription":{"label":"Company Description","value":"Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for autoimmune and inflammatory diseases, degenerative diseases, and cancer-related to the liver. Its clinical pipeline includes drug assets for Crohn's Disease, COVID19, Secondary Progressive Multiple Sclerosis, and Hepatocellular Carcinoma. Its development pipeline includes Foralumab, Milciclib, Anti-IL6R, and Others. The company has a single reporting segment, which is the research and development of biotechnological & pharmaceutical products."},"CompanyUrl":{"label":"Company Url","value":"https://www.tizianalifesciences.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Ivor Elrifi","title":"Chief Executive Officer"},{"name":"Matthew W. Davis","title":"Chief Operating & Medical Officer"},{"name":"Vaseem A. Palejwala","title":"Senior Director-Clinical Operations"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}